| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18507 R78640 |
Broe (Controls unexposed, general pop), 2025 | Major congenital malformations (exclusion of chromosomal abnormalities (ICD-10 codes Q90– Q99)) | 1st trimester | population based cohort retrospective | unexposed (general population or NOS) excluded | Adjustment: Yes Paracetamol use: prescription or medical files |
1.12 [1.01;1.26] excluded (control group) |
384/8,590 16,928/471,855 | 17,312 | 8,590 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18508 R78641 |
Broe (Controls unexposed, sick), 2025 | Major congenital malformations (exclusion of chromosomal abnormalities (ICD-10 codes Q90– Q99)) | 1st trimester | population based cohort retrospective | unexposed, sick | Adjustment: Yes Paracetamol use: prescription or medical files | 1.00 [0.87;1.15] | 384/8,590 646/14,817 | 1,030 | 8,590 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18630 R79168 |
Poletta, 2012 | Single or multiple birth defects (excluding minor anomalies and syndromes) | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Paracetamol use: maternal ITW/questionnaires after pregnancy | 1.25 [1.17;1.33] C | 1,788/4,518 56,726/164,810 | 58,514 | 4,518 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18505 R78735 |
Rebordosa a, 2008 | Major congenital abnormalities | 1st trimester | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Paracetamol use: maternal ITW/questionnaires during pregnancy | 1.01 [0.93;1.08] | 1,132/26,424 2,652/61,718 | 3,784 | 26,424 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18776 R79890 |
Nelson, 1971 | Major abnormalities | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No Matched Paracetamol use: maternal ITW/questionnaires after pregnancy Paracetamol use: prescription or medical files | 1.16 [0.25;5.41] C | 2/11 173/1,075 | 175 | 11 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 4 studies | 1.09 [0.93;1.27] | 63,503 | 39,543 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, sick;
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded 18507